{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:28:27Z","timestamp":1790497707738,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3134,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>We previously reported that peripheral blood mononuclear cells (PBMCs) from patients with primary biliary cirrhosis (PBC) produce significantly higher levels of polyclonal IgM than controls after exposure to CpG. Furthermore, the prevalence and unusually high levels of antimitochondrial antibodies (AMAs) in patients with PBC suggest a profound loss of B cell tolerance. We have addressed the issue of whether CpG will promote the production of AMAs and whether new experimental agents that inhibit the lymphocyte potassium channels Kv1.3 and KCa3.1 can suppress CpG-mediated B cell activation and AMA production. PBMCs were stimulated with and without CpG and were subsequently analyzed for phenotype, including expression of TLR9, CD86, and KCa3.1 concurrent with measurements of AMA and responses to a control antigen, tetanus toxoid, in supernatants. Additionally, K+ channel expression on B cells from PBC patients and controls was studied using whole-cell patch-clamp technology. In patients with PBC, CpG induces secretion of AMAs in PBMCs and also up-regulates B cell expression of TLR9, CD86, and KCa3.1. Additionally, K+ channel blockers suppress secretion of AMA without a reduction of CpG-B\u2013enhanced IgM production. Furthermore, there is diminished up-regulation of TLR9 and CD86 without affecting proliferation of B cells, B cell apoptosis, or viability.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>These data suggest that the hyperresponsiveness of B cells in PBC accelerates B cell\u2013mediated autoimmunity.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.21522","type":"journal-article","created":{"date-parts":[[2007,1,26]],"date-time":"2007-01-26T23:25:09Z","timestamp":1169853909000},"page":"314-322","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":73,"title":["AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers"],"prefix":"10.1097","volume":"45","author":[{"given":"Yuki","family":"Moritoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Xiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Xiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Y.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross L.","family":"Coppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20241201","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.1840080128","article-title":"Primary biliary cirrhosis and mitochondrial autoantigensinsights from molecular biology.","volume":"8","author":"Gershwin","year":"1988","journal-title":"Hepatology"},{"key":"R2-9-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2006.04.006","article-title":"New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis.","volume":"239","author":"He","year":"2006","journal-title":"Cell Immunol"},{"key":"R3-9-20241201","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20052438","article-title":"TLR9MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.","volume":"203","author":"Ehlers","year":"2006","journal-title":"J Exp Med"},{"key":"R4-9-20241201","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"ChromatinIgG complexes activate B cells by dual engagement of IgM and Tolllike receptors.","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"R5-9-20241201","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1074-7613(03)00323-6","article-title":"Activation of autoreactive B cells by CpG dsDNA.","volume":"19","author":"Viglianti","year":"2003","journal-title":"Immunity"},{"key":"R6-9-20241201","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2004.11.005","article-title":"Bacterial CpG induces hyperIgM production in CD27() memory B cells in primary biliary cirrhosis.","volume":"128","author":"Kikuchi","year":"2005","journal-title":"Gastroenterology"},{"key":"R7-9-20241201","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tips.2004.03.010","article-title":"K channels as targets for specific immunomodulation.","volume":"25","author":"George Chandy","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"R8-9-20241201","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI16921","article-title":"The voltagegated Kv1.3 K() channel in effector memory T cells as new target for MS.","volume":"111","author":"Wulff","year":"2003","journal-title":"J Clin Invest"},{"key":"R9-9-20241201","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.173.2.776","article-title":"K channel expression during B cell differentiation: implications for immunomodulation and autoimmunity.","volume":"173","author":"Wulff","year":"2004","journal-title":"J Immunol"},{"key":"R10-9-20241201","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1124\/mol.104.008193","article-title":"Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.","volume":"67","author":"Beeton","year":"2005","journal-title":"Mol Pharmacol"},{"key":"R11-9-20241201","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.241497298","article-title":"Selective blockade of T lymphocyte K() channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.","volume":"98","author":"Beeton","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-9-20241201","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/eji.200425954","article-title":"Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice.","volume":"35","author":"Reich","year":"2005","journal-title":"Eur J Immunol"},{"key":"R13-9-20241201","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1359\/jbmr.0301213","article-title":"Selective blockade of voltagegated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.","volume":"19","author":"Valverde","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R14-9-20241201","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","article-title":"Primary biliary cirrhosis.","volume":"362","author":"Talwalkar","year":"2003","journal-title":"Lancet"},{"key":"R15-9-20241201","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"R16-9-20241201","doi-asserted-by":"crossref","first-page":"37137","DOI":"10.1074\/jbc.M003941200","article-title":"Upregulation of the IKCa1 potassium channel during Tcell activation. Molecular mechanism and functional consequences.","volume":"275","author":"Ghanshani","year":"2000","journal-title":"J Biol Chem"},{"key":"R17-9-20241201","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults.","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"key":"R18-9-20241201","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.510240117","article-title":"Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.","volume":"24","author":"Moteki","year":"1996","journal-title":"Hepatology"},{"key":"R19-9-20241201","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/hep.20175","article-title":"Caspase induction by IgA antimitochondrial antibody: IgAmediated biliary injury in primary biliary cirrhosis.","volume":"39","author":"Matsumura","year":"2004","journal-title":"Hepatology"},{"key":"R20-9-20241201","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.161.8.3912","article-title":"B lymphocytes are critical antigenpresenting cells for the initiation of T cellmediated autoimmune diabetes in nonobese diabetic mice.","volume":"161","author":"Serreze","year":"1998","journal-title":"J Immunol"},{"key":"R21-9-20241201","first-page":"640","article-title":"Potassium channels as therapeutic targets for autoimmune disorders.","volume":"6","author":"Wulff","year":"2003","journal-title":"Curr Opin Drug Discov Devel"},{"key":"R22-9-20241201","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2003.11.033","article-title":"Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?","volume":"40","author":"Abdulkarim","year":"2004","journal-title":"J Hepatol"},{"key":"R23-9-20241201","first-page":"918","article-title":"Analysis of TCR antagonism and molecular mimicry of an HLAA0201restricted CTL epitope in primary biliary cirrhosis.","volume":"36","author":"Kita","year":"2002","journal-title":"Hepatology"},{"key":"R24-9-20241201","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobioticmetabolizing bacterium.","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"R25-9-20241201","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1053\/jhep.2000.18714","article-title":"Fine specificity of T cells reactive to human PDCE2 163176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and crossrecognition among mitochondrial autoantigens.","volume":"32","author":"Shigematsu","year":"2000","journal-title":"Hepatology"},{"key":"R26-9-20241201","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1084\/jem.181.5.1835","article-title":"HLA DRB4 0101restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.","volume":"181","author":"Shimoda","year":"1995","journal-title":"J Exp Med"},{"key":"R27-9-20241201","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/jhep.2000.8090","article-title":"Mimicry peptides of human PDCE2 163176 peptide, the immunodominant Tcell epitope of primary biliary cirrhosis.","volume":"31","author":"Shimoda","year":"2000","journal-title":"Hepatology"},{"key":"R28-9-20241201","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.coph.2004.02.009","article-title":"The role of the BAFFAPRIL system in B cell homeostasis and lymphoid cancers.","volume":"4","author":"Mackay","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"R29-9-20241201","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry.","volume":"11","author":"McClain","year":"2005","journal-title":"Nat Med"},{"key":"R30-9-20241201","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2004.05.033","article-title":"Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis.","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"R31-9-20241201","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.172.2.954","article-title":"IL12p70dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.","volume":"172","author":"Wagner","year":"2004","journal-title":"J Immunol"},{"key":"R32-9-20241201","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1074\/jbc.M105902200","article-title":"Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma.","volume":"277","author":"Suvas","year":"2002","journal-title":"J Biol Chem"},{"key":"R33-9-20241201","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"R34-9-20241201","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.20010956","article-title":"Identification of HLAA2restricted CD8() cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes crosspresented by dendritic cells.","volume":"195","author":"Kita","year":"2002","journal-title":"J Exp Med"},{"key":"R35-9-20241201","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDCE2specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.","volume":"109","author":"Kita","year":"2002","journal-title":"J Clin Invest"},{"key":"R36-9-20241201","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/hep.1840180315","article-title":"Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis.","volume":"18","author":"Nakanuma","year":"1993","journal-title":"Hepatology"},{"key":"R37-9-20241201","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hep.20248","article-title":"Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse.","volume":"39","author":"Palmer","year":"2004","journal-title":"Hepatology"},{"key":"R38-9-20241201","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.20642","article-title":"A key role for autoreactive B cells in the breakdown of Tcell tolerance to pyruvate dehydrogenase complex in the mouse.","volume":"41","author":"Robe","year":"2005","journal-title":"Hepatology"},{"key":"R39-9-20241201","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI4213","article-title":"Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.","volume":"102","author":"Shimoda","year":"1998","journal-title":"J Clin Invest"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21522","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200702000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:13:34Z","timestamp":1733058814000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200702000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21522","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}